Literature DB >> 22226510

Nuclear localization of matrix metalloproteinases.

Ferdinando Mannello1, Virginia Medda.   

Abstract

Matrix metalloproteinases (MMPs) were originally identified as matrixin proteases that act in the extracellular matrix. Recent works have uncovered nontraditional roles for MMPs in the extracellular space as well as in the cytosol and nucleus. There is strong evidence that subspecialized and compartmentalized matrixins participate in many physiological and pathological cellular processes, in which they can act as both degradative and regulatory proteases. In this review, we discuss the transcriptional and translational control of matrixin expression, their regulation of intracellular sorting, and the structural basis of activation and inhibition. In particular, we highlight the emerging roles of various matrixin forms in diseases. The activity of matrix metalloproteinases is regulated at several levels, including enzyme activation, inhibition, complex formation and compartmentalization. Most MMPs are secreted and have their function in the extracellular environment. MMPs are also found inside cells, both in the nucleus, cytosol and organelles. The role of intracellular located MMPs is still poorly understood, although recent studies have unraveled some of their functions. The localization, activation and activity of MMPs are regulated by their interactions with other proteins, proteoglycan core proteins and / or their glycosaminoglycan chains, as well as other molecules. Complexes formed between MMPs and various molecules may also include interactions with noncatalytic sites. Such exosites are regions involved in substrate processing, localized outside the active site, and are potential binding sites of specific MMP inhibitors. Knowledge about regulation of MMP activity is essential for understanding various physiological processes and pathogenesis of diseases, as well as for the development of new MMP targeting drugs.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22226510     DOI: 10.1016/j.proghi.2011.12.002

Source DB:  PubMed          Journal:  Prog Histochem Cytochem        ISSN: 0079-6336


  43 in total

Review 1.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

2.  Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia.

Authors:  Yi Yang; Eduardo Candelario-Jalil; Jeffrey F Thompson; Eloy Cuadrado; Eduardo Y Estrada; Anna Rosell; Joan Montaner; Gary A Rosenberg
Journal:  J Neurochem       Date:  2009-10-15       Impact factor: 5.372

3.  Cell in situ zymography: an in vitro cytotechnology for localization of enzyme activity in cell culture.

Authors:  Aastha Chhabra; Astha Jaiswal; Umang Malhotra; Shrey Kohli; Vibha Rani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-07-21       Impact factor: 2.416

Review 4.  Matrix Metalloproteinases During Axonal Regeneration, a Multifactorial Role from Start to Finish.

Authors:  Lien Andries; Inge Van Hove; Lieve Moons; Lies De Groef
Journal:  Mol Neurobiol       Date:  2016-02-29       Impact factor: 5.590

5.  MMP14 is required for delamination of chick neural crest cells independently of its catalytic activity.

Authors:  Cyril Andrieu; Audrey Montigny; Anne Bibonne; Evangeline Despin-Guitard; Dominique Alfandari; Eric Théveneau
Journal:  Development       Date:  2020-04-12       Impact factor: 6.868

6.  Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease.

Authors:  Rafaelle Christine Gomes Fares; Juliana de Assis Silva Gomes; Luciana Ribeiro Garzoni; Mariana Caldas Waghabi; Roberto Magalhães Saraiva; Nayara Ingrid Medeiros; Roberta Oliveira-Prado; Luiz Henrique Conde Sangenis; Mayara da Costa Chambela; Fernanda Fortes de Araújo; Andréa Teixeira-Carvalho; Marcos Paulo Damásio; Vanessa Azevedo Valente; Karine Silvestre Ferreira; Giovane Rodrigo Sousa; Manoel Otávio da Costa Rocha; Rodrigo Correa-Oliveira
Journal:  Infect Immun       Date:  2013-07-15       Impact factor: 3.441

7.  Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen-glucose deprivation in neurons.

Authors:  J W Hill; R Poddar; J F Thompson; G A Rosenberg; Y Yang
Journal:  Neuroscience       Date:  2012-06-16       Impact factor: 3.590

Review 8.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

Review 9.  Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors.

Authors:  Liqin Li; Heng Li
Journal:  Cancer Biol Ther       Date:  2013-08-05       Impact factor: 4.742

Review 10.  Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking.

Authors:  Charles A Galea; Hai M Nguyen; K George Chandy; Brian J Smith; Raymond S Norton
Journal:  Cell Mol Life Sci       Date:  2013-08-03       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.